| Literature DB >> 26967152 |
Laurens H J Kleijn1, Sabine F Oppedijk2, Peter 't Hart1, Roel M van Harten1, Leah A Martin-Visscher3, Johan Kemmink1, Eefjan Breukink2, Nathaniel I Martin1.
Abstract
Laspartomycin C is a lipopeptide antibiotic with activity against a range of Gram-positive bacteria including drug-resistant pathogens. We report the first total synthesis of laspartomycin C as well as a series of structural variants. Laspartomycin C was found to specifically bind undecaprenyl phosphate (C55-P) and inhibit formation of the bacterial cell wall precursor lipid II. While several clinically used antibiotics target the lipid II pathway, there are no approved drugs that act on its C55-P precursor.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26967152 DOI: 10.1021/acs.jmedchem.6b00219
Source DB: PubMed Journal: J Med Chem ISSN: 0022-2623 Impact factor: 7.446